US jobs data provides boost

The better-than-expected jobless claims figures from the US helped turn the market around.

Equities were well and truly offside for the first half of the day, but some positive signs from the US labour market showed that the Federal Reserve’s stimulus package is working. Economists were expecting the number of people claiming unemployment benefit to increase but it actually fell by 12,000. This provided traders with a reason to buy back into the equity market.

In London the banking sector finished broadly unchanged, except for RBS which fell lower due to the announcement that Stephen Hester will be stepping down. Mr Hester took the helm at the height of the credit crisis and guided the bailed-out bank away from the brink of collapse. Since the announcement the stock has lost 3%.

In the US the Dow is up 40 points at 15,035, as the better-than-estimated jobless claims figures from the US helped the market find positive ground. Chemical maker Dupont lowered its guidance-for-operating profit for the year as the poor weather in Europe and North America hit its agricultural business. The share price is down 0.6%.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.